Literature DB >> 15501798

Toll-like receptor 4-dependent early elicited tumor necrosis factor alpha expression is critical for innate host defense against Bordetella bronchiseptica.

Paul B Mann1, Kelly D Elder, Mary J Kennett, Eric T Harvill.   

Abstract

Toll-like receptor 4 (TLR4) mediates the response to lipopolysaccharide, and its activation induces the expression of a large number of inflammatory genes, many of which are also induced by other pathogen-associated molecular patterns. Interestingly, the subset of genes that are dependent on TLR4 for optimal expression during gram-negative bacterial infection has not been determined. We have previously shown that TLR4-deficient mice rapidly develop acute pneumonia after inoculation with Bordetella bronchiseptica, suggesting that TLR4 is required for expression of early elicited gene products in this model. Microarray analysis with macrophages derived from wild-type and TLR4-deficient mice was used to identify genes whose expression, within 1 h of bacterial exposure, is dependent on TLR4. The results of this investigation suggest that TLR4 is not required for the majority of the transcriptional response to B. bronchiseptica. However, early tumor necrosis factor alpha (TNF-alpha) mRNA expression is primarily dependent on TLR4 and in vitro and in vivo protein levels substantiate this finding. TLR4-deficient mice and TNF-alpha-/- mice are similarly susceptible to infection with relatively low doses of B. bronchiseptica and in vivo neutralization studies indicate that it is the TLR4-dependent early elicited TNF-alpha response that is critical for preventing severe pneumonia and limiting bacterial growth. These results suggest that one critical role for TLR4 is the generation of a robust but transient TNF-alpha response that is critical to innate host defense during acute gram-negative respiratory infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15501798      PMCID: PMC523027          DOI: 10.1128/IAI.72.11.6650-6658.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  41 in total

Review 1.  The Toll receptor family and microbial recognition.

Authors:  R Medzhitov; C Janeway
Journal:  Trends Microbiol       Date:  2000-10       Impact factor: 17.079

2.  Stereotyped and specific gene expression programs in human innate immune responses to bacteria.

Authors:  Jennifer C Boldrick; Ash A Alizadeh; Maximilian Diehn; Sandrine Dudoit; Chih Long Liu; Christopher E Belcher; David Botstein; Louis M Staudt; Patrick O Brown; David A Relman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

3.  Reversing lipopolysaccharide toxicity by ligating the macrophage Fc gamma receptors.

Authors:  J S Gerber; D M Mosser
Journal:  J Immunol       Date:  2001-06-01       Impact factor: 5.422

Review 4.  Toll-like receptors as potential therapeutic targets for multiple diseases.

Authors:  Claudia Zuany-Amorim; John Hastewell; Christoph Walker
Journal:  Nat Rev Drug Discov       Date:  2002-10       Impact factor: 84.694

5.  Human macrophage activation programs induced by bacterial pathogens.

Authors:  Gerard J Nau; Joan F L Richmond; Ann Schlesinger; Ezra G Jennings; Eric S Lander; Richard A Young
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

6.  Pregenomic comparative analysis between bordetella bronchiseptica RB50 and Bordetella pertussis tohama I in murine models of respiratory tract infection.

Authors:  E T Harvill; P A Cotter; J F Miller
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

7.  Ontogeny of Toll-like receptors Tlr2 and Tlr4 in mice.

Authors:  K Harju; V Glumoff; M Hallman
Journal:  Pediatr Res       Date:  2001-01       Impact factor: 3.756

8.  MHCII, Tlr4 and Nramp1 genes control host pulmonary resistance against the opportunistic bacterium Pasteurella pneumotropica.

Authors:  S K Chapes; D A Mosier; A D Wright; M L Hart
Journal:  J Leukoc Biol       Date:  2001-03       Impact factor: 4.962

9.  Molecular evolution and host adaptation of Bordetella spp.: phylogenetic analysis using multilocus enzyme electrophoresis and typing with three insertion sequences.

Authors:  A van der Zee; F Mooi; J Van Embden; J Musser
Journal:  J Bacteriol       Date:  1997-11       Impact factor: 3.490

10.  Toll-like receptor 4 mediates innate immune responses to Haemophilus influenzae infection in mouse lung.

Authors:  Xiaorong Wang; Christian Moser; Jean-Pierre Louboutin; Elena S Lysenko; Daniel J Weiner; Jeffrey N Weiser; James M Wilson
Journal:  J Immunol       Date:  2002-01-15       Impact factor: 5.422

View more
  24 in total

1.  Contribution of Bordetella filamentous hemagglutinin and adenylate cyclase toxin to suppression and evasion of interleukin-17-mediated inflammation.

Authors:  Michael W Henderson; Carol S Inatsuka; Amanda J Sheets; Corinne L Williams; David J Benaron; Gina M Donato; Mary C Gray; Erik L Hewlett; Peggy A Cotter
Journal:  Infect Immun       Date:  2012-04-02       Impact factor: 3.441

2.  Host genetics of Bordetella pertussis infection in mice: significance of Toll-like receptor 4 in genetic susceptibility and pathobiology.

Authors:  H A Banus; R J Vandebriel; H de Ruiter; J A M A Dormans; N J Nagelkerke; F R Mooi; B Hoebee; H J van Kranen; T G Kimman
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

3.  Interleukin-1 receptor signaling is required to overcome the effects of pertussis toxin and for efficient infection- or vaccination-induced immunity against Bordetella pertussis.

Authors:  Xuqing Zhang; Sara E Hester; Mary J Kennett; Alexia T Karanikas; Liron Bendor; David E Place; Eric T Harvill
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

4.  Use of a genetically defined double mutant strain of Bordetella bronchiseptica lacking adenylate cyclase and type III secretion as a live vaccine.

Authors:  Paul Mann; Elizabeth Goebel; James Barbarich; Mylisa Pilione; Mary Kennett; Eric Harvill
Journal:  Infect Immun       Date:  2007-04-23       Impact factor: 3.441

5.  Constraint-based network model of pathogen-immune system interactions.

Authors:  Juilee Thakar; Assieh Saadatpour-Moghaddam; Eric T Harvill; Réka Albert
Journal:  J R Soc Interface       Date:  2008-10-24       Impact factor: 4.118

6.  Comparative toll-like receptor 4-mediated innate host defense to Bordetella infection.

Authors:  Paul B Mann; Daniel Wolfe; Eicke Latz; Douglas Golenbock; Andrew Preston; Eric T Harvill
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

7.  Role of pagL and lpxO in Bordetella bronchiseptica lipid A biosynthesis.

Authors:  I MacArthur; J W Jones; D R Goodlett; R K Ernst; A Preston
Journal:  J Bacteriol       Date:  2011-07-15       Impact factor: 3.490

8.  Role of the type III secretion system in a hypervirulent lineage of Bordetella bronchiseptica.

Authors:  Anne M Buboltz; Tracy L Nicholson; Laura S Weyrich; Eric T Harvill
Journal:  Infect Immun       Date:  2009-07-13       Impact factor: 3.441

Review 9.  Bordetella pertussis pathogenesis: current and future challenges.

Authors:  Jeffrey A Melvin; Erich V Scheller; Jeff F Miller; Peggy A Cotter
Journal:  Nat Rev Microbiol       Date:  2014-03-10       Impact factor: 60.633

10.  Cross-Foster Rederivation Compared with Antibiotic Administration in the Drinking Water to Eradicate Bordetella pseudohinzii.

Authors:  Sarah E Clark; Jeanette E Purcell; Xuan Bi; Jeffrey D Fortman
Journal:  J Am Assoc Lab Anim Sci       Date:  2017-01-01       Impact factor: 1.232

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.